Anti-Mouse CD19 (1D3)
CD19 Monoclonal Antibody for FC
Host / Isotype
Rat / IgG2a, kappa
Reactivity
mouse
Applications
FC
Conjugate
Unconjugated
CloneNo.
1D3
Cat no : 65290-1-Ig
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | mouse splenocytes |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
65290-1-Ig targets CD19 in FC applications and shows reactivity with mouse samples.
Tested Reactivity | mouse |
Host / Isotype | Rat / IgG2a, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | Mouse CD19 Transfected Cell Line 相同性解析による交差性が予測される生物種 |
Full Name | CD19 antigen |
GenBank accession number | BC156767 |
Gene symbol | Cd19 |
Gene ID (NCBI) | 12478 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
Background Information
CD19 is a 95 kDa type I transmembrane glycoprotein belonging to the immunoglobulin superfamily (PMID: 2472450). It is expressed by B cells and follicular dendritic cells. CD19 is up-regulated at the step of B-lineage commitment during the differentiation of the hematopoietic stem cell, it remains on during subsequent stages of differentiation until finally down-regulated during terminal differentiation into plasma cells (PMID: 8528044). CD19 is involved in B cell development, activation and differentiation. It is the dominant component for the signaling complex on B cells that includes CD21 (CR2), CD81 (TAPA-1) and CD225 and acts as a critical co-receptor for BCR signal transduction (PMID: 23210908).
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CD19 antibody 65290-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |